Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EUDA Health HoldingsEUDA -2.76%43 3-Year EPS without NRI Growth Rate is 46.40% as of Dec. 2025, which is 744% above its 10-year median of 5.50. GuruFocus rates EUDA with a GF Score™ of 43/100 and a GF Value™ of $63.30 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,324 Real Estate companies, EUDA Health Holdings ranks better than 86.86% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 46.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 6 years, the highest 3-Year average EPS without NRI Growth Rate of EUDA Health Holdings was 46.40% per year. The lowest was -35.40% per year. And the median was 5.50% per year.
EUDA Health Holdings (NAS:EUDA) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
EUDA Health Holdings 3-Year EPS without NRI Growth Rate Related Terms
EUDA vs FTHM, ASPS, NYC: 3-Year EPS without NRI Growth Rate Comparison
For the Real Estate Services subindustry, EUDA Health Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EUDA Health Holdings 3-Year EPS without NRI Growth Rate vs Real Estate Industry
For the Real Estate industry and Real Estate sector, EUDA Health Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where EUDA Health Holdings's 3-Year EPS without NRI Growth Rate falls into.
EUDA Health Holdings 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 46.40% mean?
EUDA Health Holdings (EUDA) has a 3-Year EPS without NRI Growth Rate of 46.40% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for EUDA Health Holdings and its competitors. This is 744% above median its historical median of 5.50. According to the industry distribution chart, EUDA Health Holdings ranks #174 out of 1324 companies in the Real Estate industry, placing it in the top 13.1%.
Is EUDA Health Holdings' 3-Year EPS without NRI Growth Rate too high?
EUDA Health Holdings' current 3-Year EPS without NRI Growth Rate of 46.40% is 744% above median its 10-year median of 5.50. The Real Estate industry median 3-Year EPS without NRI Growth Rate is 4.45. EUDA Health Holdings' value of 46.40% is 942.7% above this industry median. Based on the distribution chart, EUDA Health Holdings ranks #174 out of 1324 companies in the Real Estate industry, which is in the top quartile — a strong position relative to peers. Overall, EUDA Health Holdings has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EUDA Health Holdings' 3-Year EPS without NRI Growth Rate compare to FTHM and ASPS?
According to the Real Estate industry distribution chart, EUDA Health Holdings ranks #174 out of 1324 companies for 3-Year EPS without NRI Growth Rate. This places EUDA Health Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 4.45. EUDA Health Holdings' value of 46.40% is 942.7% above this benchmark. While the company's 10-year median is 5.50 vs. the industry median of 4.45, EUDA Health Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Real Estate company?
The median 3-Year EPS without NRI Growth Rate among Real Estate companies is 4.45, based on 1,324 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EUDA Health Holdings's current 3-Year EPS without NRI Growth Rate of 46.40% is 942.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for EUDA Health Holdings and its competitors. For the Real Estate industry, the median 3-Year EPS without NRI Growth Rate is 4.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EUDA Health Holdings's current 3-Year EPS without NRI Growth Rate is 46.40%, which is 744% above median its own 10-year median of 5.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EUDA Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, EUDA Health Holdings (EUDA) is currently considered Possible Value Trap. The stock's GF Value™ is $63.30, compared to a current price of $14.62 — trading 76.9% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 46.40%, which is 744% above median its 10-year median of 5.50 and 942.7% above the Real Estate industry median of 4.45. EUDA Health Holdings' overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For EUDA Health Holdings (EUDA), the current 3-Year EPS without NRI Growth Rate is 46.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EUDA Health Holdings (EUDA) Overvalued in 2026?
Based on GuruFocus' analysis, EUDA Health Holdings stock appears to be undervalued.
The current stock price of $14.62 is trading 76.9% below its estimated GF Value™ of $63.30.
GuruFocus considers EUDA Health Holdings to be Possible Value Trap.
Key valuation signals for EUDA:
3-Year EPS without NRI Growth Rate: 46.40% (744% above median its 10-year median of 5.50)
GF Value™: $63.30 vs. price of $14.62 (76.9% below fair value)
Industry Position: 942.7% above the Real Estate median (#174 of 1324)
No single metric tells the full story. See the EUDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.
43GF Score
Get the complete analysis for EUDA
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EUDA has been successfully added to your 
